Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Time to first cleavage24 hours
time of embryo to undergo first cleavage
- Time to blastulation5-7 days
time of embryo to form a blastocoel
- Fertilization morphology24 hours
the morphological appearance of the pronuclei
- Embryo morphology2-7 days
the morphological appearance of the embryos
- Patient age0 days
Patient age
- Partner age0 days
Partner age
- Partner diagnosis0 days
Partner diagnosis
- Metabolomics of culture media7 days
measurement of the spent culture media for amino acids, enzymes, and metabolites
- AMH0 days
antimullerian hormone level in female's blood
- Days of stimulation0-15 days
the number of days the patient underwent stimulation for IVF
- Dosage of stimulation meds0-15 days
the amount of stimulation meds the patient took during IVF treatment
- Pregnancy2 weeks after transfer
initial bhCG levels
- Patient diagnosis0 days
Number of patients with each specific diagnosis, including low ovarian reserve, PCOS, primary infertility, secondary infertility, endometrosis, and unknown infertility.
- implantation4 weeks post transfer
Number of patients that develope a sac within the uterus post transfer
- fetal cardiac heartbeat6 weeks
Number of patients that develop a fetal cardiac heartbeat after transfer
- livebirthapproximately 9 months after transfer
Number of patients that have a livebirth of an infant after IVF